People | October 01, 2022
Philips shareholders appoint Roy Jakobs as next President and CEO
Roy is the right successor to lead Philips’ efforts to help improve the health and well-being of people globally
Roy is the right successor to lead Philips’ efforts to help improve the health and well-being of people globally
They also noted ProBioGen's digitalization investments and strategy, as well as its support for its employees.
Post-acquisition, Cipla EU's stake in the subsidiary will increase to 93.10%.
The Phase IV DREAM-CKD trial will enrol 1004 CKD patients in India, including 502 dialysis dependent, 502 dialysis independent CKD patients with anemia.
The funding round also saw participation from some of India's top angel investors and leading industry giants
ExoBrite antibody conjugates are validated and optimized for bright and specific detection of exosome markers
OS-SiA is the industry’s first AI-enabled digital scanner that will provide real-time predictive analysis and actionable insights
Results from the DELIVER and DAPA-HF Phase III trials demonstrate Dapagliflozin’ efficacy in heart failure regardless of ejection fraction
Key senior hire will partner with Allison Ceraso, President and CCO, bolstering agency leadership amongst continued network momentum
The study will evaluate the effectiveness of Nantheia ATL5, an investigational drug using cannabidiol in ANANDA’s proprietary delivery technology
Subscribe To Our Newsletter & Stay Updated
